Mediation Analysis
Mediation Analysis - Related Videos
09:19
Analysis of SNARE-mediated Membrane Fusion Using an Enzymatic Cell Fusion Assay
0 Views •
2012
We have developed a cell fusion assay that quantifies SNARE-mediated membrane fusion events by activated expression of β-galactosidase.
14:16
Analysis of Physiologic E-Selectin-Mediated Leukocyte Rolling on Microvascular Endothelium
0 Views •
Cited by 32 •
2009
This report provides a visual depiction of parallel-plate flow chamber analysis for studying leukocyte endothelial interactions under physiologic shear stress. This method is particularly useful for investigating the role of endothelial (E)-selectin and leukocyte E-selectin ligands that trigger leukocyte rolling on endothelial cell surfaces.
02:19
Lentiviral-Mediated Transduction of Human Neurons for Tau Protein Aggregation Analysis
0 Views •
2025
This video demonstrates the process of transducing human neuronal cells with a lentivirus encoding a mutant human tau protein tagged with yellow fluorescent protein (YFP) to study protein aggregation. It outlines the steps from viral entry to mutant tau expression, culminating in the formation of visible cytoplasmic tau aggregates in the neurons.
02:27
Nonsense-mediated mRNA Decay
0 Views •
2020
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs. Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
09:01
Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models
0 Views •
Cited by 3 •
2023
This paper presents the methodology for obtaining and assessing vascular calcification by isolating murine aortas followed by extracting calcified extracellular vesicles to observe the mineralization potential.
FAQs
Interpretation depends on recognizing that the indirect estimate concerns the selected intermediate variable, not every possible biological route. The total effect describes the exposure-outcome relationship overall, while the indirect component reflects transmission through that mediator. The direct component represents the remaining effect not transmitted through the proposed mediator, including pathways that the analysis did not explicitly model.
Confounding can make an apparent mediated pathway reflect preexisting differences rather than the proposed process. Adjustment seeks to account for factors that influence the exposure, mediator, or outcome and could distort their relationships. In immunology and infection research, this safeguard is especially important when interpreting links among an intervention, immune response, pathogen burden, and clinical outcome.
Mediation Analysis differs from a simple exposure-outcome association because it asks whether a specified intermediate helps account for that relationship. An association may show that exposure and outcome vary together, but it does not by itself identify a direct or indirect route. Regression or related causal models provide a structured way to evaluate the proposed pathway.
The chosen mediator determines which biological explanation the analysis can test. Selecting immune cell activation, cytokine signaling, or pathogen burden leads to different interpretations of the indirect component, even for the same exposure and outcome. Researchers should align the mediator with the hypothesized mechanism and use a design and adjustment strategy capable of supporting that interpretation.
A typical workflow begins by specifying the exposure, outcome, and proposed mediator, then selecting regression or another causal model suited to estimating their relationships. Researchers estimate the overall exposure effect and the components associated with the proposed pathway while applying appropriate confounding adjustment. The resulting estimates indicate whether the mediator plausibly contributes to the observed outcome relationship.
Results can support biomarker selection by showing whether a measured immune or infection-related variable lies on a pathway associated with an outcome. They may also help prioritize potential intervention targets, including mechanisms relevant to vaccines, therapeutics, or infection control. These uses depend on interpreting pathway estimates within the study's design and confounding-adjustment limits.
In immunology and infection, the method can connect an intervention or exposure with clinical or biological outcomes through immune cell activation, cytokine signaling, or pathogen burden. The analysis can organize evidence about whether an observed outcome is associated with an immune response or another pathway, making it useful for mechanistic interpretation across biological and clinical endpoints.